12 Central Labs for Clinical Trials in 2026

A central lab provider gives a multi-site clinical trial a single, harmonized source of truth for routine safety testing, specialty assays, and sample logistics — a role that becomes more important as trials add sites across more countries and time zones. A central laboratory service clinical trials sponsor chooses often comes down to geographic footprint and assay menu breadth as much as brand recognition, since a study running in a specific region may need a lab with an established local presence and regulatory accreditation there. For Sponsors and CROs evaluating a clinical trial central lab vendor, understanding whether a provider operates its own wholly-owned network or works through regional partner labs can matter for turnaround time and data harmonization.

The labs below, presented in no particular order, range from independent regional specialists to labs operating as part of larger global diagnostics and CRO groups. Between them they cover multi-country central lab networks, region-specific partnerships in Japan and Indonesia, human biospecimen processing, and blood-disorder specialty testing.

ACM Global Laboratories

ACM Global Laboratories has provided central laboratory testing services for global clinical trials since 1975, and the company states it now operates in more than 65 countries through wholly-owned facilities in the US, England, India, and Singapore alongside a network of partner labs. An affiliate of Rochester Regional Health, the company states its staff perform more than 20 million tests annually across pathology, microbiology, molecular diagnostics, and toxicology. ACM Global Laboratories is based in Rochester, New York.

CB Trial Laboratory

CB Trial Laboratory is a central laboratory in Kawagoe, Saitama, Japan jointly managed by Labcorp Drug Development and BML, a Japanese clinical laboratory testing provider, under a partnership dating back to 2010. The two companies broke ground in 2023 on an expansion providing more than 4,000 square meters of additional dedicated space, more than five times the size of the original facility, adding genomics, microbiology, and companion diagnostics capabilities alongside existing flow cytometry and pathology services. The expanded laboratory was targeted for completion in early 2025.

Cerba Research

Cerba Research operates as the clinical trial laboratory division of Cerba HealthCare, a diagnostics group founded in Paris in 1967, running a network of specialty laboratories that the company states spans 12 sites across five continents alongside a global central laboratory network. Its European hub in Ghent, Belgium anchors biomarker and bioanalytical testing, while a Rotterdam, Netherlands facility focuses on virology, and Cerba expanded its bioanalytical and central lab capabilities in North America through its 2023 acquisition of Cirion BioPharma Research in Canada.

DiagnoSearch Life Sciences

DiagnoSearch Life Sciences operates what the company describes as India's first central laboratory dedicated exclusively to clinical research, established in 1996 as part of a full-service CRO founded in Mumbai in 1995. The company states its CAP- and NABL-accredited central laboratory has supported clinical trials across Phases I-IV for nearly three decades, and DiagnoSearch maintains active clinical operations teams across India, Bangladesh, Southeast Asia, and several countries in West and East Africa.

IQVIA Laboratories

IQVIA Laboratories, formerly known as Q² Solutions, traces its origins to a 2015 joint venture between Quintiles (now IQVIA) and Quest Diagnostics that combined the two companies' clinical trial laboratory operations; IQVIA acquired full ownership of the joint venture in 2021 for roughly $760 million. The company states it operates central laboratory, genomics, flow cytometry, and bioanalytical services from a global network of wholly-owned laboratories, and it opened new Innovation Laboratories in North Carolina in 2021 to unite multiple laboratory disciplines for biomarker development. IQVIA Laboratories is headquartered in Durham, North Carolina.

LabConnect

LabConnect provides central laboratory and functional service provider solutions for clinical trials, with a particular focus on the customized sample collection kits used in complex studies such as cell and gene therapy. Founded in 2002 and relocated from Seattle to Johnson City, Tennessee in 2020, the company states its kits are distributed to more than 70 countries and it has supported more than 1,900 clinical studies across 93 countries over more than two decades. LabConnect has continued to expand its Johnson City facility, including doubling its biorepository and kit-building capacity in 2020.

Labcorp

Labcorp traces its roots to Roche Biomedical Laboratories, founded in Burlington, North Carolina in 1978, and built its central laboratory business into an industry leader through its 2015 acquisition of Covance for roughly $6 billion. The company states its central labs business offers more than 1,200 assays across a laboratory network spanning three continents, and it maintains a long-standing central lab partnership with BML in Japan alongside its own wholly-owned facilities, including one of Europe's largest central labs in Geneva, Switzerland. Labcorp spun off its clinical development business as Fortrea in 2023 while retaining its central laboratory network.

Precision for Medicine

Precision for Medicine combines central laboratory services with specialty biomarker assay capabilities, positioning its central lab offering as a complement to complex, biomarker-driven trial designs rather than a standalone commodity service. Based in Carlsbad, California, the company operates central and specialty labs across the US and Europe, including an accredited facility in Berlin, Germany that supports immune monitoring services such as flow cytometry and cytokine profiling. Precision for Medicine states it has built a virtual master sample inventory system that gives sponsors centralized, dashboard-based visibility into sample compliance across sites.

Prodia the CRO

Prodia the CRO operates Indonesia's first and, the company states, only CAP-accredited central laboratory for clinical trials, established in 1997 as a spin-off of Prodia Laboratory's existing central lab work that began in 1991. The company entered an exclusive multi-year partnership with Quintiles (now IQVIA) in 2011 giving the CRO access to Prodia's central laboratory for international studies, and it draws on sister company Prodia Laboratory's network of more than 250 outlets across Indonesia to reach clinical trial sites. Prodia the CRO is based in Jakarta.

REPROCELL Europe

REPROCELL Europe, originally founded as Biopta in 2002, has specialized in handling fresh human biospecimens for more than two decades, and the company states it added central laboratory and precision medicine services to its original human tissue research work. Japan's REPROCELL acquired Biopta and fellow Scottish company Reinnervate in 2015, and REPROCELL Europe now operates from the West of Scotland Science Park in Glasgow, working under GLP/GCLP quality standards with 24/7 biosafety level 2 facilities. The company also partners with the Precision Medicine Scotland Innovation Centre on translational research.

Sonic Clinical Trials

Sonic Clinical Trials operates as a dedicated, NATA-accredited central laboratory and subsidiary of Sonic Healthcare, an Australian-owned diagnostics group the company states employs more than 36,000 people across Australia, New Zealand, the UK, Germany, Belgium, Ireland, and Switzerland. Based in Macquarie Park, New South Wales, the company draws on Sonic Healthcare's Independent Practitioners Network for access to GP investigators and patient populations across Australia, and it has partnered with Asia-Pacific CRO Novotech since 2017 to offer central lab services alongside Novotech's clinical trial management.

Versiti Clinical Trial Services

Versiti Clinical Trial Services operates as part of Versiti, a Milwaukee-based blood health organization formed in 2019 through the rebranding of the BloodCenter of Wisconsin, combining central lab, complex diagnostics, and regulatory consulting services for sponsors developing therapeutics, diagnostics, and devices. The company states it draws on Versiti's broader diagnostic laboratory capabilities, including HLA typing, immunohematology reference lab testing, and hematology genetics testing, built on the organization's decades of blood banking and transfusion medicine experience. Versiti Clinical Trial Services works alongside the Versiti Blood Research Institute, located on the Milwaukee Regional Medical Center campus.

Explore the full Central Labs landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 250 Central Labs, many with Vendor qualification data available on demand. Book a demo to explore Diligent's full vendor discovery database.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.